.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Novartis
Fish and Richardson
Covington
Daiichi Sankyo
Baxter
Cerilliant
Colorcon
Argus Health
Federal Trade Commission

Generated: September 20, 2017

DrugPatentWatch Database Preview

Baclofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for baclofen and what is the scope of baclofen patent protection?

Baclofen
is the generic ingredient in four branded drugs marketed by Northstar Hlthcare, Mylan, Watson Labs, Ivax Sub Teva Pharms, Mylan Pharms Inc, Lannett, Teva, Novartis, Vintage Pharms, Usl Pharma, Piramal Critical, Sun Pharm Inds Inc, Impax Labs, Saol Theraps Res Ltd, Caraco, Oxford Pharms, Ucb Inc, and Emerald Intl Ltd, and is included in twenty-eight NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Baclofen has thirteen patent family members in nine countries.

There are eighteen drug master file entries for baclofen. Forty-seven suppliers are listed for this compound.

Summary for Generic Name: baclofen

Tradenames:4
Patents:2
Applicants:18
NDAs:28
Drug Master File Entries: see list18
Suppliers / Packagers: see list47
Bulk Api Vendors: see list75
Clinical Trials: see list92
Patent Applications: see list7,208
Therapeutic Class:Antispasticity Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:baclofen at DailyMed

Pharmacology for Ingredient: baclofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms
BACLOFEN
baclofen
TABLET;ORAL077156-001Aug 30, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
BACLOFEN
baclofen
TABLET;ORAL073043-001Feb 27, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
BACLOFEN
baclofen
TABLET;ORAL072235-001Jul 21, 1988ABRXNoYes► Subscribe► Subscribe► Subscribe
Oxford Pharms
BACLOFEN
baclofen
TABLET;ORAL077088-002Oct 31, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
BACLOFEN
baclofen
TABLET;ORAL074698-001Aug 20, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
BACLOFEN
baclofen
TABLET;ORAL077241-001Dec 20, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
BACLOFEN
baclofen
TABLET;ORAL074584-002Aug 19, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Novartis
LIORESAL
baclofen
TABLET;ORAL017851-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs
BACLOFEN
baclofen
TABLET;ORAL073093-001Jan 28, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
KEMSTRO
baclofen
TABLET, ORALLY DISINTEGRATING;ORAL021589-001Oct 30, 2003DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: baclofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
LIORESAL
baclofen
TABLET;ORAL017851-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Novartis
LIORESAL
baclofen
TABLET;ORAL017851-003Jan 20, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: baclofen

Country Document Number Estimated Expiration
European Patent Office0975336► Subscribe
Denmark2147669► Subscribe
Australia6896998► Subscribe
Australia726336► Subscribe
Spain2525720► Subscribe
Japan5072513► Subscribe
Japan2012162558► Subscribe
Hong Kong1137654► Subscribe
Japan2008001726► Subscribe
European Patent Office2266538► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Queensland Health
QuintilesIMS
Chinese Patent Office
Healthtrust
Cipla
Fuji
Farmers Insurance
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot